tirzepatide anesthesia guidelines How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like glp-1 drugs and anesthesia tirzepatide

2010 Jan] Author: Zhang H, Jia H, Liu J, Ao N, Yan B, Shen W, Wang X, Li X, Luo C, Liu J

Surma et al., 2011)

Letko M, Seifert SN, Olival KJ, Plowright RK, Munster VJ

Reality: While generally safe when administered correctly, there are potential side effects, particularly if used improperly

If more than 4 days have passed, skip the missed dose entirely and resume your regular dosing schedule

We also explored several other known regulators of PGC1 activity that are altered in response to 5FU treatment in HCT116, including NRF2, reactive oxygen species and PPAR, but none of these prevented PGC1-driven increases in mitochondrial mass